Sikh inhibitor

摘要

The pharmacology components transmitted by the invention include a compound containing a formula, a pharmaceutically acceptable formula salt or a hydrate, and at least one pharmaceutically acceptable polymer. 1. A pharmaceutically acceptable salt in a formula compound or its hydrate may be a Messiah salt, for example, including a monosaccharide salt or a bismesilato salt or one of its hydrates. In addition, methods of drug synthesis have been spread